This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Jan 1;117(1):6-8.

doi: 10.1161/CIRCULATIONAHA.107.747337.

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors

PMID: 18172046
DOI: 10.1161/CIRCULATIONAHA.107.747337

Review

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors

Harold L Lazar. Circulation. 2008.

. 2008 Jan 1;117(1):6-8.

doi: 10.1161/CIRCULATIONAHA.107.747337.

Author

PMID: 18172046
DOI: 10.1161/CIRCULATIONAHA.107.747337

No abstract available

PubMed Disclaimer

Comment on

Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D, Myers MG, Calciu CD, Dalle-Ave S, Martineau P, Mormont C, van Gilst WH; IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators. Rouleau JL, et al. Circulation. 2008 Jan 1;117(1):24-31. doi: 10.1161/CIRCULATIONAHA.106.685073. Epub 2007 Dec 10. Circulation. 2008. PMID: 18071079 Clinical Trial.

Similar articles

The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery.
Lazar HL. Lazar HL. Vascul Pharmacol. 2005 Feb;42(3):119-23. doi: 10.1016/j.vph.2005.01.012. Vascul Pharmacol. 2005. PMID: 15792929 Review.
Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient.
Lazar HL. Lazar HL. Ann Thorac Surg. 2005 Mar;79(3):1081-9. doi: 10.1016/j.athoracsur.2004.05.046. Ann Thorac Surg. 2005. PMID: 15734453 Review.
Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
Benedetto U, Melina G, Capuano F, Comito C, Bianchini R, Simon C, Refice S, Angeloni E, Sinatra R. Benedetto U, et al. J Cardiovasc Med (Hagerstown). 2008 Nov;9(11):1098-103. doi: 10.2459/JCM.0b013e32830a6daf. J Cardiovasc Med (Hagerstown). 2008. PMID: 18852580
Cardiac medical therapy following coronary artery bypass graft surgery.
Chacko KA. Chacko KA. J Am Coll Cardiol. 2005 Sep 6;46(5):934; author reply 934-5. doi: 10.1016/j.jacc.2005.06.003. J Am Coll Cardiol. 2005. PMID: 16139150 No abstract available.
Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery.
Arora R, Sowers JR, Saunders E, Probstfield J, Lazar HL. Arora R, et al. J Card Surg. 2006 Mar-Apr;21(2):198-204. doi: 10.1111/j.1540-8191.2006.00210.x. J Card Surg. 2006. PMID: 16492288 Review.

See all similar articles

Cited by

Impact of Renin-Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery.
Antoniak DT, Walters RW, Alla VM. Antoniak DT, et al. J Am Heart Assoc. 2021 May 18;10(10):e019731. doi: 10.1161/JAHA.120.019731. Epub 2021 May 8. J Am Heart Assoc. 2021. PMID: 33969701 Free PMC article.
Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
Zou Z, Yuan HB, Yang B, Xu F, Chen XY, Liu GJ, Shi XY. Zou Z, et al. Cochrane Database Syst Rev. 2016 Jan 27;2016(1):CD009210. doi: 10.1002/14651858.CD009210.pub2. Cochrane Database Syst Rev. 2016. PMID: 26816003 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information